Differences in Incidence of Common Side Effects Between Young Adults and Elderly Patients While Using IV-PCA

CompletedOBSERVATIONAL
Enrollment

10,575

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Pain, PostoperativePostoperative Nausea and Vomiting
Interventions
DEVICE

Fentanyl based IV-PCA

We have used a disposable PCA pump (Ambix Anaplus®; E-Wha Fresenius Kabi, Korea or accufuser plus®; Woo Young Medical, Korea) and fentanyl was diluted in 100 mL with saline for 48 hrs PCA infusion. The pump was set as follows: infusion rate as 2 ml/hr, bolus dose as 0.5 ml or 1 ml, lockout time as 15 min. It was decided at the anesthesiologist's option whether the additional analgesic drug (ketorolac or nefopam) and the antiemetic drug (ondansetron, ramosetron or palonosetron) would be added in PCA or not. The anesthesiologist who performed the anesthesia decided the amount of chosen drugs.

Trial Locations (1)

135-720

Gangnam Severance hospital, Seoul

All Listed Sponsors
lead

Severance Hospital

OTHER

NCT02448862 - Differences in Incidence of Common Side Effects Between Young Adults and Elderly Patients While Using IV-PCA | Biotech Hunter | Biotech Hunter